This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Oct;13(5):142.

doi: 10.1136/ebm.13.5.142.

Risk of cancer was still increased over 2 years after stopping hormone therapy

Angela M Cheung¹

Affiliations

PMID: 18836110
DOI: 10.1136/ebm.13.5.142

Comment

Risk of cancer was still increased over 2 years after stopping hormone therapy

Angela M Cheung. Evid Based Med. 2008 Oct.

. 2008 Oct;13(5):142.

doi: 10.1136/ebm.13.5.142.

Author

Angela M Cheung¹

Affiliation

¹ University of Toronto, Toronto, Ontario, Canada.

PMID: 18836110
DOI: 10.1136/ebm.13.5.142

No abstract available

PubMed Disclaimer

Comment on

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators. Rossouw JE, et al. JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321. JAMA. 2002. PMID: 12117397 Clinical Trial.

Publication types

Actions

Grants and funding

44917/CAPMC/ CIHR/Canada

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.